CDTTW
CDT Equity Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.01
+0.00%Price chart
Jul 23Jul 31Aug 6Aug 12Aug 18Aug 21Aug 28Sep 3
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
4.0x
Market Cap
$419813.00
MomentumView details →
1D Return
+0.00%
YTD Return
+92.73%
RSI (14)
48.3
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
4.0x
Market Cap
$419813.00
RSI (14)
48.3
MomentumView details →
1D Return
+0.00%
YTD Return
+92.73%
Similar companies
Latest newsMore news →
CDT Equity Inc. issued a senior secured convertible promissory note to J.J. Astor & Co. in the principal amount of $541,620.8h agoJames Bligh was appointed Chief Executive Officer of CDT Equity Inc., effective 2026-08-31, succeeding Andrew Regan who resigned as CEO and director with severance of $50,000 per month for six months.4d agoCDT Equity Inc. announced an investment in US-based peptide company Pep'd Inc. via a SAFE note, expanding into the US peptide market.11d ago